课题基金 / 基金详情

Investigating variation in the inpatient allocation of scarce COVID-19 therapeutics: Equity and Clinical Outcomes

Investigating variation in the inpatient allocation of scarce COVID-19 therapeutics: Equity and Clinical Outcomes
调查稀缺 COVID-19 疗法住院患者分配的变化:公平性和临床结果
批准号:
473341
负责人:
Razak Fahad
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-09-01 至 2023-09-01

项目摘要

项目成果

Razak Fahad的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The COVID-19 pandemic created an urgent need for effective therapeutics to treat hospitalized patients with severe COVID-19. In less than two years, new drugs were developed, and existing medications were repurposed to provide a range of treatment approac
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A pragmatic randomized trial to evaluate the effect of a peer-comparison feedback letter on antimicrobial use in hospital-based physicians
  • 批准号:
    483302
  • 项目类别:
    Operating Grants
  • 资助金额:
    $21.86万
  • 财政年份:
    2023
  • 负责人:
    Razak Fahad
  • 依托单位:
A pragmatic randomized trial to evaluate the effect of a peer-comparison feedback letter on antimicrobial use in hospital-based physicians
  • 批准号:
    490409
  • 项目类别:
    Operating Grants
  • 资助金额:
    $46.26万
  • 财政年份:
    2023
  • 负责人:
    Razak Fahad
  • 依托单位:
Investigating variation in the inpatient allocation of scarce COVID-19 therapeutics: Equity and Clinical Outcomes
  • 批准号:
    465297
  • 项目类别:
    Operating Grants
  • 资助金额:
    $29.14万
  • 财政年份:
    2022
  • 负责人:
    Razak Fahad
  • 依托单位:
Canada Research Chair - Tier 2
  • 批准号:
    471126
  • 项目类别:
  • 资助金额:
    $43.71万
  • 财政年份:
    2022
  • 负责人:
    Razak Fahad
  • 依托单位:
海外基金